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MinireviewA Turn of the Helix:
Preventing the Glial Fate
cells in vivo, and the fate choices made by individual
cells or defined cell populations can be followed and
manipulated (Rao, 1999). Taking advantage of this, Sun
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genesis and gliogenesis in multipotent cortical progeni-
tor cells. Overexpression of the bHLH factor neuro-
genin1 (ngn1) caused enhanced neuronal differentiation
The development of the nervous system is a carefully and loss of progenitor cell markers, consistent with a
orchestrated process resulting in the ordered generation role for ngn1 in positively regulating neurogenesis. Nota-
of the mature cellular elements of the central nervous bly, ngn1 also reduced the ability of multipotent progeni-
system: neurons, astrocytes, and oligodendrocytes. All tor cells to differentiate into astrocytes, even in response
of these cell types arise from progenitors that are initially to treatment with the cytokine LIF/CNTF, which normally
multipotent but gradually become restricted in their promotes astrocyte differentiation. This suggested that
potential to either the neuronal or glial lineage (Gage, ngn1 expression was able to actively inhibit the ability
2000). Differentiation occurs in a stereotyped sequence of progenitors to respond to glial-inducing cues.
whereby neurons are generated first, followed by glial Is the inhibition of astrocyte differentiation a direct
cells, which differentiate after neurogenesis is largely effect or an indirect consequence of promoting neuro-
complete (Bayer and Altman, 1991). One of the most genesis? Sun et al. (2001) found that ngn1 could inhibit
fundamental decisions faced by progenitor cells during the expression of glial-specific genes, but that this was
development is whether to generate neurons or glia. independent of its ability to promote neurogenesis. The
There has been considerable interest recently in under- authors introduced a promoter for the astrocyte marker
standing how this choice is regulated. glial fibrillary acidic protein (GFAP) coupled to a lucifer-
A subset of transcription factors belonging to the ba- ase reporter into astrocyte-enriched cortical cultures.
sic helix-loop-helix (bHLH) family have long been recog- By monitoring luciferase activity, they found that ngn1
nized for their ability to positively regulate the neuronal inhibited activation of this reporter construct. However,
fate decision in both invertebrates and vertebrates (Lee, two observations showed that the inhibitory activity of
1997). Knockout studies in mice have revealed that ngn1 was independent of DNA binding. First, the region
bHLH factors are required for the development of dis- of the promoter that responded to ngn1 inhibition did
tinct subpopulations of neurons. Conversely, overex- not contain E boxes, which are the binding sequences
pression of various proneural bHLH factors in Xenopus for bHLH factors, and second, mutations in ngn1 that
embryos is sufficient to convert ectodermal cells into interfered with DNA binding did not prevent inhibition
neurons. It has been less appreciated to what extent of the reporter construct. In contrast, the ability of ngn1
bHLH factors contribute to the glial fate decision. Since to promote neurogenesis did require DNA binding and
most neurons are generated before gliogenesis begins, activation of transcriptional targets such as the bHLH
there must be regulatory mechanisms in place to coordi- factor NeuroD. These important observations suggest
nate the timing of differentiation of these cell popula- that the proneural activity of ngn1 can be uncoupled
tions. Several recent papers highlight a central role for from the glial inhibitory activity.
bHLH factors in this process and provide a mechanistic Competition for Limiting Cofactors
understanding of how bHLH factors required for neuro- If ngn1 does not need to bind DNA to inhibit glial specific
genesis delay the onset of gliogenesis. gene expression, what is the mechanism underlying this
NGN1 Suppresses Glial Development In Vitro inhibition? A clue was provided through analysis of the
How do bHLH factors influence the fate choices of indi- GFAP promoter when it was found that one of the most
important elements for inhibition by ngn1 contained avidual progenitor cells? To determine at what step in
STAT binding site. STAT proteins are essential compo-the differentiation process bHLH factors are functioning,
nents of the signaling pathway activated by cytokinesthe fate decisions made by defined progenitor cells dur-
such as LIF/CNTF, which can promote astrocyte differ-ing development must be followed. This is difficult to
entiation (Bonni et al., 1997). Binding of CNTF to itsdo in vivo and is complicated by the fact that during
receptor activates an associated tyrosine kinase, thedevelopment progenitor cells are exposed to complex
Janus kinase (JaK1), which phosphorylates the STATenvironmental cues that influence cell fate decisions,
proteins, resulting in their translocation to the nucleushampering attempts to tease apart the mechanisms
(Leonard and O’Shea, 1998). In order for STAT proteinscontributing to any given fate choice. Recent advances
to activate expression of target genes, such as GFAP,in neural stem cell research have made it possible to
they must bind to the transcriptional coactivator CBP/explore the mechanisms regulating progenitor cell dif-
p300. Sun et al. (2001) found that Ngn1 also binds toferentiation by analyzing these events in vitro. Multipo-
CBP/p300 and can prevent this essential coactivatortent progenitor cells in culture can differentiate to give
from associating with the STAT proteins, thus blockingrise to neurons, astrocytes, and oligodendrocytes, simi-
activation of glial-specific genes. The ability of ngn1 tolar to what has been observed for multipotent progenitor
sequester CBP/p300 was independent of its ability to
bind DNA, explaining how the glial inhibitory activity of
ngn1 could be uncoupled from its ability to promote* E-mail: monica.vetter@hsc.utah.edu
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neurogenesis. Ngn1 was also found to inhibit phosphor-
ylation of the STAT proteins through an unknown mech-
anism, suggesting that multiple mechanisms may be
used by ngn1 to inhibit gliogenesis.
Lif/CNTF can also synergize with bone morphogenetic
proteins (BMPs) to promote astrocyte differentiation
(Nakashima et al., 1999). BMP signaling by receptor
binding leads to phosphorylation of Smad proteins,
which then translocate to the nucleus. Smad1 binds to
CBP/p300, which also interacts with STAT proteins, thus
Smad1 is recruited to glial promoters through its indirect
association with STAT proteins. In contrast, BMP stimu-
lation of cortical progenitors in which ngn1 is expressed
elicits neuronal differentiation. In this case, the CBP/
p300-Smad1 complex preferentially interacts with ngn1
to induce neurogenesis at the expense of gliogenesis
(Sun et al., 2001). Once again, the ability of ngn1 to
sequester CBP/p300 and associated proteins has an
inhibitory effect on gliogenesis.
Based upon these results, it is reasonable to propose
that CBP/p300 is limiting in cortical progenitor cells,
thus precluding neurogenesis and gliogenesis from oc-
curring simultaneously. This model suggests that when
ngn1 is expressed in progenitors during normal develop-
ment, neurogenesis is actively promoted through activa-
Figure 1. bHLH Factors Controlling Neurogenesis Suppress Glio-tion of ngn1 target genes, while gliogenesis is inhibited
genesisthrough sequestration of CBP/p300 and through inhibi-
Treatment of cortical progenitors with CNTF promotes astrocytetion of STAT phosphorylation. When ngn1 levels drop
differentiation. In reponse to CNTF stimulation, STAT proteins be-later in development, CBP/p300 would become avail-
come phosphorylated, translocate to the nucleus, and interact with
able for recruitment to the promoters of glial-specific the transcriptional coactivator CBP/p300 to regulate glial-specific
genes. To test this idea, Sun et al. (2001) showed that gene expression. Expression of the bHLH factor neurogenin 1 (ngn1)
coexpressing CBP with ngn1 in cortical progenitors re- in progenitors suppresses glial differentiation in two ways. Ngn1
sequesters CBP/p300 so that it is not available for association withlieves the inhibition of astrocyte differentiation by ngn1.
STAT proteins, thus preventing activation of glial-specific genes. InThis suggests that exogenous ngn1 is only inhibitory to
addition, ngn1 can prevent phosphorylation of STAT proteins ingliogenesis when CBP/p300 levels are limiting. Is this
response to CNTF through an unknown mechanism.
also true for endogenous ngn1? Sun et al. (2001) found
that endogenous CBP/p300 coimmunoprecipitated with
endogenous STAT3 from extracts of P3 cortical subven-
ngn2 (Fode et al., 2000). Therefore, Nieto et al. (2001)
tricular zone, where ngn1 expression is not expressed
isolated progenitors from Mash1/ngn2 double knockoutand glia are being generated. However, in extracts from
animals and tested for their ability to differentiate inE14 cortex, when ngn1expression is high and neurogen-
culture. They found a decrease in the proportion ofesis is taking place, CBP/p300 was bound to ngn1, but
strictly neuronal clones and an increase in the proportionnot to STAT3, even though STAT3 was expressed. This
of mixed clones that contained both neurons and GFAP-argues that CBP/p300 is also limiting with respect to
positive astrocytes. In general, these clones were largerendogenous levels of STAT3 and ngn1, although this
and consisted of predominantly astrocytes, with only ahas not been tested directly.
few neurons. The authors concluded that the loss ofLoss of bHLH Factors Causes Enhanced Gliogenesis
these two bHLH factors increased the probability thatTogether, these findings suggest a model in which ngn1
cortical progenitors would differentiate into glia.interferes with glial differentiation by binding to the tran-
Nieto et al. (2001) also found that cortical progenitorsscriptional coactivator CBP/p300 and limiting its avail-
are heterogeneous in their expression of ngn2. Usingability for activation of glial-specific genes (Figure 1). A
cells derived from animals heterozygous for a knockinprediction of this model is that precocious or enhanced
of b-galactosidase into the ngn2 locus, the authors wereglial differentiation should occur when bHLH factor ex-
able to sort progenitors expressing ngn2 from those notpression is eliminated. This has not been directly exam-
expressing ngn2. When this was done in a Mash1 mutantined in ngn1 knockout animals. However, Nieto et al.
background, it was found that clones derived from pro-(2001) analyzed the differentiation of progenitors derived
genitors expressing ngn2, but not Mash1, differentiatedfrom ngn2 and Mash1 knockout animals to determine
normally, while those derived from progenitors lackingwhether there were any effects on neuronal or glial differ-
both ngn2 and Mash1 were much more likely to containentiation. Ngn2 and Mash1 are both expressed in the
only GFAP-positive astrocytes. Although it has not yetgerminal layers of the developing cerebral cortex, with
been shown whether ngn2 or Mash1 can sequester CBP/ngn2 being expressed at high levels and Mash1 at low
p300 in a manner similar to ngn1, this data suggestslevels. When the ngn2 gene is disrupted, there is compen-
that loss of expression of these bHLH factors biasessatory upregulation of Mash1 expression, which masks
effects on neurogenesis or gliogenesis due to loss of progenitor cells toward adopting a glial fate in vitro,
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consistent with the model described above. Other bHLH tors in vivo does also not appear to be sufficient to
inhibit glial differentiation. Cai et al. (2000) overex-factors are expressed in the developing central nervous
system, so it will be important to test whether these pressed various bHLH factors, including ngn1, in vivo
using retroviral vectors and found that some bHLH fac-factors can also regulate gliogenesis through interaction
with CBP/p300. tors, including ngn1, ngn2, and Mash1, could cause a
modest increase in the proportion of infected corticalThe Neuronal/Glial Fate Decision In Vivo
In vivo, the levels of endogenous bHLH factor expres- progenitors that differentiated into neurons. In addition,
there was a corresponding modest inhibition of glialsion have the potential to regulate the availability of
CBP/p300 for gliogenesis, and loss of bHLH factor ex- differentiation, but neither astrocyte differentiation nor
oligodendrocyte differentiation was completely sup-pression in vivo should cause precocious or enhanced
gliogenesis. The effects of loss of bHLH factor function pressed in infected cells. Since the levels of Ngn1 pro-
tein were not directly examined, it is possible that lowon neurogenesis and gliogenesis in vivo have been ana-
lyzed in double knockout animals by Nieto et al. (2001) levels of exogenous bHLH factor expression limited the
effects on gliogenesis. Nevertheless, the findings of Caiand Tomita et al. (2000). There were much more dramatic
effects on cortical development in ngn2/Mash1 double et al. (2000) suggest that additional factors may be suffi-
cient to promote gliogenesis in a CBP/p300-indepen-knockout animals than seen with either single mutant
alone (Nieto et al., 2001). There was a dramatic decrease dent manner. Several recent studies have found that
activation of the Notch pathway can promote glial devel-in the numbers of differentiating neurons at E12.5 and
E13.5, consistent with a requirement for these bHLH opment (Wang and Barres, 2000). Furthermore, Tanigaki
et al. (2001) provide evidence that Notch-dependent ac-factors in neurogenesis. By E15.5, the ventricular zone in
ngn2/Mash1 double mutant animals was disorganized, tivation of GFAP does not depend upon the STAT bind-
ing site in the GFAP promoter. Further studies underwith BrDU-positive cells no longer restricted to the ven-
tricular surface, and the distributions of ventricular zone more defined conditions will be necessary to determine
whether these pathways or others can override inhibi-and subventricular zone markers disturbed. There were
also effects on glial populations in these animals. At tion of gliogenesis by bHLH factors such as ngn1. Nota-
bly, overexpression of bHLH factors is sufficient to blockE15.5, the radial glia were disorganized and by E18.5
showed morphological signs of premature differentia- Mu¨ller glial differentiation in the retina in vivo (Cai et al.,
2000), suggesting that there may be regional differencestion along the astrocytic pathway, which normally oc-
curs much later. In addition, glial markers, such as BLBP, in the ability of bHLH factors to regulate gliogenesis in
the CNS.tenascinC, and Hes5, were expressed by cells found
scattered throughout the cortex. Similarly, in Mash1/ Negative Regulation of Oligodendrocyte
DevelopmentMath3 double knockout animals, Tomita et al. (2000)
found reduced neurogenesis and increased astrocytic Oligodendrocytes are also derived from multipotent pro-
genitors, although the effect of proneural bHLH factorsdifferentiation in the tectum, hindbrain, and retina. How-
ever, there was enhanced cell death in the ventricular on their differentiation has not yet been established.
However, recent evidence suggests that a positively actingzone of Mash1/Math3 knockout animals, raising the pos-
sibility that neural progenitors were dying and glial pro- bHLH factor likely regulates their development, and that
the timing of oligodendrocyte differentiation is regulatedgenitor differentiation was increased as a secondary
consequence. by inhibiting bHLH activity. Oligodendrocytes differentiate
from proliferating oligodendrocyte precursors (OPCs)Although there was evidence of increased numbers
of cells becoming committed to the glial lineage, and (Rogister et al., 1999). Using a degenerate PCR ap-
proach to examine the profile of HLH factors expressedearly astrocytic markers were expressed, consistent
precocious expression of GFAP was not detected in the in purified OPCs, Wang et al. (2001 [this issue of Neuron])
found that these cells express high levels of Id2, a HLHcortex of Mash1/ngn2 double mutant animals, or in the
tectum of Mash1/Math3 double mutant animals, indicat- protein that lacks the DNA binding basic domain. Id
proteins can inhibit the activity of positively acting bHLHing that in these regions complete astrocyte differentia-
tion did not occur (Tomita et al., 2000; Nieto et al., 2001). factors by heterodimerizing with them and preventing
DNA binding. The authors found that overexpressingThis suggests that in some parts of the nervous system,
loss of bHLH expression is not by itself sufficient to Id2 in oligodendrocyte precursors efficiently blocked
their differentiation. This finding would predict that dur-result in the formation of mature astrocytes. It is possible
that additional bHLH factors, such as ngn1, continue to ing normal development in order for OPCs to begin dif-
ferentiation, endogenous Id2 inhibition must be relieved.be expressed in progenitors in these regions and pre-
vent premature astrocyte differentiation. Alternatively, Wang et al. (2001) demonstrated that in OPCs stimulated
to differentiate in culture, Id2 protein translocated outother signals that are temporally and spatially regulated
may be required. For example, signals known to pro- of the nucleus prior to the onset of differentiation.
If Id2 is functioning to inhibit oligodendrocyte differen-mote astrocyte development, such as ligands for the
Notch receptor, are expressed by differentiating neu- tiation in OPCs, then OPCs lacking Id2 should differenti-
ate prematurely. Since the Id2 knockout mice die in therons. Since the numbers of differentiating neurons are
reduced in the mutant animals, appropriate signals for early postnatal period, this was assessed using OPCs
purified from P5 Id2 mutant mice. OPCs lacking Id2complete astrocyte differentiation may be missing. Al-
ternatively, astrocyte-promoting signals may be tempo- expression showed a modest increase in the rate of
differentiation and a significant decrease in proliferation.rally regulated, precluding premature differentiation, even
in the absence of bHLH factor expression. The fact that a more dramatic effect on the rate of differ-
entiation was not observed argues that additional mech-Overexpression of bHLH factors in cortical progeni-
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anisms must be in place to regulate the timing of OPC derstanding how these events happen in the complex
differentiation. Kondo and Raff (2000) provide evidence cellular environment encountered by these cells in vivo.
that Hes5 also plays a role in regulating the timing of Nevertheless, the recent studies highlighted above are
OPC differentiation. Although oligodendrocyte-specific significant for providing an illuminating glimpse into the
bHLH transcription factors such as olg1 and olg2 have mechanisms governing the neuronal/glial fate decision
been identified recently (Lu et al., 2000; Zhou et al., during development.
2000), it is not yet clear whether Id2 is acting to inhibit
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Together, the studies highlighted above provide us
with unprecedented insight into the molecular mecha-
nisms regulating the neuronal/glial fate choice during
development and demonstrate that bHLH factor expres-
sion can be an important contributor to this decision.
Will these advances enhance our ability to use neural
stem cells to therapeutically treat nervous system dis-
ease and injury? There is no doubt that defining the
molecular mechanisms governing stem cell differentia-
tion will make this much more likely. Sun et al. (2001)
have suggested a therapeutic application for their work
by stating that manipulation of proneural bHLH factor
expression could be used to enhance the probability
that neural stem cells differentiate into neurons rather
than glia in vivo. However, sustained expression of bHLH
factors in differentiated neurons in vivo eventually
causes neuronal cell death (Cai et al., 2000), suggesting
caution about this approach. In the end, we must still
make the leap from controlling the differentiation of
these cells under defined conditions in culture, and un-
